Differential Regulation of TCR‐Induced ZFP36 and ZFP36L1 Expression by Cyclosporin A in CD8 + T Cells
European Journal of Immunology · 2025
DOI: 10.1002/eji.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Marian Jones Evans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK. Hauptthemen laut MEDLINE: Tristetraprolin, Cyclosporine, CD8-Positive T-Lymphocytes, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Wellcome.
Abstract (Originalsprache)
CD8 + T cells target infected or malignant cells via the production of pro‐inflammatory cytokines and direct target cell killing. Members of the ZFP36‐family of RNA‐binding proteins, ZFP36 and ZFP36L1, regulate these functions in T cells via the regulation of mRNA stability and protein translation. We investigate the regulation of ZFP36 and ZFP36L1 expression using in vitro differentiated OT1 TCR transgenic memory‐like T cells. We characterise the differential kinetics and sensitivity of ZFP36 and ZFP36L1 to antigen affinity and PMA versus ionomycin stimulation. By selectively inhibiting TCR‐induced signalling pathways, we find that p38 MAPK, MEK1/2, and PKC contribute to inducing both ZFP36 and ZFP36L1 expression. By contrast, inhibition of calcineurin using cyclosporin A potently inhibits ZFP36L1 expression while increasing and prolonging ZFP36 expression. The Zfp36 promoter contains many binding sites for the transcription factors ELK‐1/4 and few binding sites for NFAT, while the Zfp36l1 promoter contains many NFAT binding sites and few ELK1/4 binding sites. Our findings suggest that the regulation of divergent transcription factors enables calcineurin to act as a signalling node that mediates the differential regulation of ZFP36 and ZFP36L1 during T cell activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK.
ORCID-Profile: Martin Turner
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Wellcome
Zitieren
APA
Jones Evans, M., Mitchell, T. J., Zaucha, M., Petkau, G., & Turner, M. (2025). Differential Regulation of TCR‐Induced ZFP36 and ZFP36L1 Expression by Cyclosporin A in CD8 + T Cells. European Journal of Immunology. https://doi.org/10.1002/eji.70085
Vancouver
Jones Evans M, Mitchell TJ, Zaucha M, Petkau G, Turner M. Differential Regulation of TCR‐Induced ZFP36 and ZFP36L1 Expression by Cyclosporin A in CD8 + T Cells. European Journal of Immunology. 2025. doi:10.1002/eji.70085
BibTeX
@article{JonesEvans2025,
author = {Jones Evans, Marian and Mitchell, Twm J and Zaucha, Magdalena and Petkau, Georg and Turner, Martin},
title = {Differential Regulation of TCR‐Induced ZFP36 and ZFP36L1 Expression by Cyclosporin A in CD8 + T Cells},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70085}
}
EUVIMED